Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Mixed amphetamine salts: Difference between revisions

From Pharmacopedia
[checked revision][checked revision]
No edit summary
No edit summary
Line 85: Line 85:
| interactions      = Minimal in practice. Caution with other psychostimulants, including caffeine. metabolized by 2D6, so relevant caution applies.
| interactions      = Minimal in practice. Caution with other psychostimulants, including caffeine. metabolized by 2D6, so relevant caution applies.
| pregnancy_details = [https://www.ncbi.nlm.nih.gov/books/NBK501307/ Category C]. Crosses the placenta. Prenatal amphetamine exposure has been associated with low birth weight, premature delivery, and neonatal withdrawal (agitation, dysphoria, lassitude). Long-term neurodevelopmental outcomes from prescribed therapeutic exposure are less clear and likely modest, but illicit-dose exposure is associated with significant developmental impact. Decision should be individualized; many patients defer ADHD treatment during pregnancy. Excreted in breast milk in clinically significant amounts — breastfeeding generally discouraged.
| pregnancy_details = [https://www.ncbi.nlm.nih.gov/books/NBK501307/ Category C]. Crosses the placenta. Prenatal amphetamine exposure has been associated with low birth weight, premature delivery, and neonatal withdrawal (agitation, dysphoria, lassitude). Long-term neurodevelopmental outcomes from prescribed therapeutic exposure are less clear and likely modest, but illicit-dose exposure is associated with significant developmental impact. Decision should be individualized; many patients defer ADHD treatment during pregnancy. Excreted in breast milk in clinically significant amounts — breastfeeding generally discouraged.
| monitoring        = * Baseline: cardiovascular history, blood pressure, heart rate, weight/height, mental health history (especially for psychosis/bipolar/substance use risk)
| monitoring        = * Baseline: cardiovascular history, weight/height, mental health history (especially for psychosis/bipolar/substance use risk), (optional) blood pressure, (optional) heart rate,
* Consider ECG if cardiac risk factors present
* At each visit: efficacy, side effects, general well-being
* At each visit: blood pressure, heart rate, weight (and height in children), efficacy, side effects, signs of misuse or diversion
* Periodically reassess continued need; consider drug holidays to assess ongoing benefit
* Periodically reassess continued need; consider drug holidays in children to assess ongoing benefit and minimize growth effects
* Sleep quality (insomnia is dose-limiting)
* Sleep quality (insomnia is dose-limiting)
| counseling        = * Take in the morning to minimize insomnia; avoid afternoon dosing.
| counseling        = * Take first thing in the morning to minimize insomnia; avoid (late) afternoon dosing.
* '''Do not crush, chew, or split Adderall XR or Mydayis capsules''' — disrupts the controlled-release mechanism. (Capsules may be opened and sprinkled on applesauce if needed.)
* '''Do not crush, chew, or split Adderall XR or Mydayis capsules''' — disrupts the controlled-release mechanism. (Capsules may be opened and sprinkled on applesauce if needed.)
* Take with or without food; high-acid beverages (orange juice, vitamin C) may reduce absorption.
* Take with or without food; high-acid beverages (orange juice, vitamin C) may reduce absorption.
* Stay well-hydrated, especially in heat or during exercise.
* Stay well-hydrated, especially in heat or during exercise.
* Eat regular meals despite appetite suppression.
* Eat regular meals despite appetite suppression.
* Do not combine with alcohol — masks effects of both, increases cardiac strain.
* Report any chest pain, palpitations, severe agitation, hallucinations, or signs of poor circulation in extremities.
* Do not share or sell — federal Schedule II controlled substance; serious legal and clinical consequences.
* Sudden discontinuation can cause a fatigue/depression "crash" — plan for it.
* Report chest pain, palpitations, severe agitation, hallucinations, or signs of poor circulation in extremities.
* Take caution: make increase bowel motility and increase risk of expelled fecal content.
* Sudden discontinuation can cause a fatigue/depression "crash" — taper or plan for it.
| anecdotes        =  
| anecdotes        =  
| seealso          = [[Dextroamphetamine]], [[Lisdexamfetamine]], [[Methylphenidate]], [[Dexmethylphenidate]], [[Modafinil]], [[Atomoxetine]], [[Methamphetamine]]
| seealso          = [[Dextroamphetamine]], [[Lisdexamfetamine]], [[Methylphenidate]], [[Dexmethylphenidate]], [[Modafinil]], [[Atomoxetine]], [[Methamphetamine]]
| references        =  
| references        =  
}}
}}